首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

2126471

呼吸分析儀市場：策略性洞察與預測（2026-2031 年）

Breath Analyzer Market - Strategic Insights and Forecasts (2026-2031)

出版日期: 2026年08月18日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計呼吸分析儀市場將維持 6.96% 的複合年成長率，從 2025 年的 20.81 億美元成長到 2031 年的 31.17 億美元。

呼吸分析儀市場正經歷顯著的變革，其驅動力包括：非侵入式診斷模式轉移、應用範圍從酒精檢測擴展到其他醫療領域，以及數位和感測器技術的日益融合。這一市場演變的特點在於，人們認知到呼吸分析具有識別與呼吸系統、代謝、感染疾病和腫瘤疾病相關的揮發性有機化合物的潛力，從而為血液採樣和其他侵入性診斷程序提供了更非侵入性的替代方案。燃料電池、半導體和紅外線吸收等先進感測器技術與數位連接和數據分析技術的融合，正在催生出更精準、便攜和聯網的呼吸分析解決方案。執法機關的酒精篩檢仍然是全球最大的設備採購來源，而美國國家公路交通安全管理局 (NHTSA) 等監管機構的合規要求等法規結構，也持續影響市場結構。醫療應用正在擴展到疾病診斷領域，透過結核病、氣喘和癌症的篩檢研究，臨床應用案例正在增加。隨著對呼吸生物標記平台、臨床檢驗研究和即時檢測 (PoC) 設備開發的大量投資，呼吸分析儀正在成為公共安全和精準醫療的重要組成部分。

市場促進因素

酒駕執法力度的加大是推動呼氣酒精偵測儀市場發展的主要動力。道路交通安全法規仍是呼氣式酒精偵測儀最主要的需求來源。美國國家公路交通安全管理局 (NHTSA) 對證據呼吸檢測設備、路邊篩檢設備、校準系統和點火器連鎖裝置技術制定了合規要求。公共部門的採購也得益於執法部門的推動，這些部門要求在路邊篩檢、證據檢測和違規者監控中採用可靠的酒精測量方法。酒精點火器連鎖裝置計畫也進一步刺激了市場需求；據美國疾病管制與預防中心 (CDC) 稱，點火器連鎖裝置在佩戴期間可將酒駕再犯率降低約 70%，從而持續推動呼氣式酒精檢測儀的使用。人們對非侵入性疾病診斷的興趣日益濃厚，並透過其在醫療領域的應用不斷擴展，進一步加速了市場成長。醫療保健系統持續評估各種方法，以取代血液檢測和侵入性診斷程序。呼氣分析有望識別與呼吸系統、代謝性疾病、感染疾病和腫瘤相關的揮發性有機化合物。這項能力吸引了眾多醫療技術公司的投資，這些公司致力於早期疾病檢測並減輕患者負擔。在結核病高發生率地區，篩檢要求日益嚴格，對快速攜帶式的診斷技術需求也隨之成長。根據世界衛生組織發布的《2024年世界結核病報告》，目前全球結核病病例報告覆蓋率已超過99%，預計2023年新增病例約820萬例。燃料電池感測器在證據收集測試中的應用，推動了對具有穩定校準特性且不易受環境干擾的高階產品類型的需求。職場和司法部門監控計畫的擴展，也持續推動了對具備數位記錄儲存、遠端監控和自動報告功能的攜帶式偵測設備的需求。

市場限制因素

醫療應用的臨床檢驗要求遠高於酒精檢測設備。疾病檢測應用也面臨比酒精檢測設備更高的挑戰。臨床檢驗研究需要大規模的患者群體、較長的試驗週期以及商業部署前的監管審查。校準和維護成本會增加整體擁有成本，並構成營運負擔，尤其對於小規模的機構和醫療設施。區域監管差異會減緩國際擴張速度並增加產品開發成本。測量干擾和讀數錯誤的風險要求持續投資於感測器改進、軟體檢驗和操作人員培訓。公共部門漫長的採購週期會顯著延長銷售週期，並導致需求模式的波動。

對技術和應用的洞察

技術發展趨勢的特點是，在新型呼吸生物標記平台中，循證檢測、數位化連接和燃料電池感測器的重要性日益凸顯。酒精檢測是最具商業性價值的應用領域，其需求主要來自酒駕執法、職場安全計畫、司法監督系統、復健計畫以及消費者自測應用。與許多新興醫療應用不同，酒精檢測受益於完善的法律規範和數十年的營運經驗。買家的需求因應用程式場景而異。執法機關優先考慮證據的準確性、證據管理的文件記錄、校準的完整性以及法庭採納性。職場偵測供應商通常優先考慮便攜性、易操作性和快速結果顯示。消費者買家則更注重價格和便利性。細分市場分析表明，競爭日益集中在感測器性能、數位化連接、軟體整合和服務支援方面。在許多需要高精度和低交叉靈敏度的實證檢測環境中，燃料電池技術仍然至關重要。能夠將可靠的感測器性能與基於雲端的報告功能和遠端設備管理相結合的供應商，在機構採購過程中更具優勢。北美仍然是呼氣酒精檢測領域最成熟的市場之一，這主要得益於美國國家公路交通安全管理局 (NHTSA) 合規要求帶來的持續更換需求、廣泛的酒駕執法行動以及點火器聯鎖裝置（啟動酒精檢測裝置）的普及。歐洲的需求則由交通安全執法、職場檢測項目以及正在進行的呼氣生物標記檢測臨床研究支撐。亞太地區擁有最廣闊的長期發展機遇，這得益於其高人口密度、不斷擴展的醫療保健體系、日益完善的交通安全措施以及嚴重的結核病負擔。隨著買家對數位化記錄儲存、遠端監控功能和自動報告功能的需求日益成長，數位連接的整合變得愈發重要。

競爭格局與策略展望

在競爭格局中，成熟的酒精檢測供應商和新興的呼氣診斷設備開發商並存，競爭較為集中，尤其是在循證酒精檢測領域，認證要求、校準專業知識和法規核准構成了准入壁壘。醫療呼氣診斷領域仍相對分散，因為許多技術仍處於檢驗和商業化階段。德爾格公司（Dragerwerk AG & Co. KGaA）在執法機關和職業安全市場的長期經驗，在商用酒精檢測系統領域保持著強大的地位。 Intoximeters, Inc. 繼續專注於實證和路邊酒精檢測設備。 Lion Laboratories Ltd. 和 Alcolizer Technology Pty Ltd. 透過其經認證的酒精檢測解決方案和產品系列，為執法機關競爭。在以醫療為中心的細分市場，競爭動態有所不同，Owlstone Medical Ltd. 投資於旨在用於疾病檢測和精準醫療應用的呼氣生物標記平台。區域供應商，例如 Uniphos Envirotronic Pvt. Ltd.、Amrutha Technologies 和 AK GlobalTech Corporation 透過本地分銷網路、成本優勢和客戶支援展開競爭。儘管准入門檻仍然適中，但認證要求、校準專業知識和法規核准對新參與企業證據檢測領域的企業構成挑戰。近期重要進展包括 Lifeloc Technologies 完成了其 SpinDetect 分析平台的生產模具和無塵室的試運行，從而能夠檢驗並早期生產下一代基於呼吸的藥物檢測技術。 PulmoBioMed 和 Sanner 也為其非侵入式深肺呼吸採樣系統 PBM-Hale 獲得了 CE 認證。 Cannabix Technologies 已開始商業化部署其大麻呼吸測試系統，該系統可以非侵入式地檢測近期 THC 攝取量。 MGC Diagnostics 發布了 Fenom Flo，這是一款用於氣喘評估的攜帶式呼氣一氧化氮分數分析儀。 Keensight Capital 收購了 Bedfont Scientific 的多數股權，增強了其在非侵入式呼吸分析儀領域的成長前景。

簡明結論

受執法部門需求、非侵入式診斷和技術創新等因素的共同推動，呼氣分析儀市場預計將持續成長。從以酒精檢測為主導的市場格局轉向公共安全和醫療保健領域的整合應用，標誌著呼氣分析技術的根本性變革。儘管臨床有效性檢驗、校準負擔和監管碎片化等挑戰依然存在，但對感測器效能、數位連接和臨床證據的策略性投資正為市場領導帶來持續的競爭優勢。長期市場前景仍樂觀，呼氣分析儀可望發展成為公共安全和精準醫療的關鍵要素，協助全球醫療保健系統打擊酒駕、進行疾病篩檢並改善病患預後。

本報告的主要特點

深入分析：對各個地區、客戶群、政策、社會經濟因素、消費者偏好和產業部門進行詳細的市場洞察。
競爭格局：我們了解主要參與者的策略舉措，並確定最佳的市場進入方式。
市場促進因素與未來趨勢：我們評估影響市場的關鍵成長要素和新興趨勢。
實用建議：我們支援制定策略決策以開發新的收入來源。
適合各類讀者：非常適合新創公司、研究機構、顧問公司、中小企業和大型企業。

公司對我們報告的使用

產業和市場洞察、機會評估、產品需求預測、打入市場策略、區域擴張、資本投資決策、監管分析、新產品開發和競爭情報。

報告範圍

歷史資料涵蓋 2021 年至 2024 年，以 2025 年為基準年，預測期為 2026 年至 2031 年。
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭對手定位、策略、市場佔有率評估和貿易分析
細分市場和區域銷售成長及預測評估
公司簡介，包括策略、產品、財務狀況和主要發展動態。

北美洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 英國
  - 德國
  - 法國
  - 西班牙
  - 其他
中東和非洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 沙烏地阿拉伯
  - UAE
  - 其他
亞太地區
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 中國
  - 日本
  - 印度
  - 韓國
  - 台灣
  - 其他

第9章：競爭環境與分析

主要公司及策略分析
市佔率分析
合併、收購、協議和合作關係
競爭環境儀錶板

第10章：公司簡介

Dragerwerk AG & Co. KGaA
Intoximeters, Inc.
Honeywell International Inc.
Owlstone Medical Ltd.
Lion Laboratories Ltd.
AK GlobalTech Corporation
Amrutha Technologies
Uniphos Envirotronic Pvt. Ltd.
Alcolizer Technology Pty Ltd.

第11章附錄

簡介目錄

Product Code: KSI061616018

The Breath Analyzer Market, sustaining a 6.96% CAGR, is expected to rise from USD 2.081 billion in 2025 to USD 3.117 billion in 2031.

The breath analyzer market is undergoing significant transformation driven by the paradigm shift toward non-invasive diagnostics, the expansion of healthcare applications beyond alcohol detection, and the growing integration of digital and sensor technologies. The market's evolution is characterized by the recognition that breath analysis offers the potential to identify volatile organic compounds associated with respiratory, metabolic, infectious, and oncological conditions, providing a less invasive alternative to blood-based and invasive diagnostic procedures. The convergence of advanced sensor technologies, including fuel cell, semiconductor, and infrared absorption, with digital connectivity and data analytics is enabling more accurate, portable, and connected breath analysis solutions. Law-enforcement alcohol screening remains the largest source of device procurement globally, with regulatory frameworks such as NHTSA conformity requirements in the United States continuing to shape market structure. Healthcare applications are expanding into disease diagnostics, with tuberculosis, asthma, and oncology screening research widening clinical use cases. The market is witnessing significant investment in breath biomarker platforms, clinical validation studies, and point-of-care device development, positioning breath analyzers as a critical component of both public safety and precision medicine.

Market Drivers

The expansion of impaired-driving enforcement programs represents the primary driver for the breath analyzer market. Road-safety regulations remain the most established source of breath analyzer demand. NHTSA maintains conformity requirements for evidential breath testing devices, roadside screening instruments, calibration systems, and ignition interlock technologies. Public-sector procurement is supported by enforcement programs that require reliable alcohol measurement for roadside screening, evidentiary testing, and offender monitoring. Alcohol ignition interlock programs are further reinforcing demand, with the U.S. Centers for Disease Control and Prevention indicating that ignition interlocks reduce repeat impaired-driving offenses by roughly 70% while installed, resulting in sustained growth in breath analyzer utilization. Growing interest in non-invasive disease diagnostics is further accelerating market growth through expansion into healthcare applications. Healthcare systems continue to evaluate alternatives to blood-based and invasive diagnostic procedures. Breath analysis offers the potential to identify volatile organic compounds associated with respiratory, metabolic, infectious, and oncological conditions. This capability has attracted investment from medical technology companies seeking earlier disease detection and lower patient burden. Tuberculosis screening requirements in high-burden regions are creating demand for rapid, portable diagnostic technologies. WHO's Global Tuberculosis Report 2024 indicates that reporting systems now cover more than 99% of global TB cases, while approximately 8.2 million people were newly diagnosed in 2023. Fuel cell sensor adoption in evidential testing is strengthening demand for premium product categories with stable calibration characteristics and lower susceptibility to environmental interference. Growth of workplace and judicial monitoring programs is generating recurring demand for portable testing devices with digital record retention, remote monitoring capability, and automated reporting features.

Market Restraints

Clinical validation requirements for medical applications create substantially higher barriers than alcohol-testing devices. Disease-detection applications face substantially higher barriers than alcohol-testing devices. Clinical validation studies require large patient populations, lengthy testing periods, and regulatory review before commercial deployment. Calibration and maintenance burdens increase total ownership costs and create operational burdens, particularly for smaller agencies and healthcare facilities. Regulatory fragmentation across jurisdictions can slow international expansion and increase product-development costs. Risk of measurement interference and false readings requires continual investment in sensor improvements, software validation, and operator training. Long public-sector procurement cycles can extend sales cycles considerably and create uneven demand patterns.

Technology and Application Insights

The technology landscape is characterized by the growing importance of fuel cell sensors for evidential testing, digital connectivity, and emerging breath biomarker platforms. Alcohol detection represents the most commercially important application segment because demand is supported by impaired-driving enforcement, workplace safety programs, judicial monitoring systems, rehabilitation programs, and consumer self-testing applications. Unlike many emerging medical uses, alcohol testing benefits from well-established regulatory frameworks and decades of operational deployment. Buyer requirements vary considerably across use cases. Law-enforcement agencies prioritize evidential accuracy, chain-of-custody documentation, calibration integrity, and legal admissibility. Workplace testing providers often emphasize portability, ease of operation, and rapid results. Consumer buyers focus more heavily on affordability and convenience. The segment analysis reveals that competition increasingly centers on sensor performance, digital connectivity, software integration, and service support. Fuel cell technology remains particularly important because many evidential testing environments require high accuracy and reduced cross-sensitivity. Suppliers able to combine reliable sensor performance with cloud-based reporting and remote device management are positioned more favorably in institutional procurement processes. North America remains one of the most established markets for breath alcohol testing, with NHTSA conformity requirements, widespread DUI enforcement programs, and ignition interlock deployment creating recurring replacement demand. European demand is supported by road-safety enforcement, occupational testing programs, and ongoing clinical research into breath biomarker detection. Asia Pacific presents the broadest long-term opportunity due to high population density, expanding healthcare systems, increasing road-safety initiatives, and substantial tuberculosis burdens. The integration of digital connectivity is becoming increasingly important as buyers increasingly seek digital record retention, remote monitoring capability, and automated reporting features.

Competitive and Strategic Outlook

The competitive landscape combines established alcohol-testing suppliers with emerging breath-diagnostics developers, with competition moderately concentrated within evidential alcohol testing where certification requirements, calibration expertise, and regulatory approvals create barriers to entry. Medical breath diagnostics remain less consolidated because many technologies are still progressing through validation and commercialization stages. Dragerwerk AG & Co. KGaA maintains a strong position in professional alcohol-testing systems through its long-standing presence in law-enforcement and occupational safety markets. Intoximeters, Inc. remains focused on evidential and roadside alcohol-testing equipment. Lion Laboratories Ltd. and Alcolizer Technology Pty Ltd. compete through certified alcohol-testing solutions and enforcement-focused product portfolios. The healthcare-focused segment exhibits different competitive dynamics, with Owlstone Medical Ltd. investing in breath biomarker platforms intended for disease detection and precision medicine applications. Regional suppliers such as Uniphos Envirotronic Pvt. Ltd., Amrutha Technologies, and AK GlobalTech Corporation compete through local distribution networks, cost positioning, and customer support capabilities. Barriers to entry remain moderate, with certification requirements, calibration expertise, and regulatory approvals creating challenges for new entrants in evidential testing segments. Recent key developments include Lifeloc Technologies completing production tooling and cleanroom commissioning for its SpinDetect analyzer platform, enabling validation and early production of next-generation breath-based drug-testing technology. PulmoBioMed and Sanner achieved CE marking for PBM-Hale, a non-invasive deep-lung breath sampling system. Cannabix Technologies began commercial rollout of its Marijuana Breath Test system, enabling non-invasive detection of recent THC consumption. MGC Diagnostics introduced Fenom Flo, a handheld fractional exhaled nitric oxide analyzer for asthma assessment. Keensight Capital acquired a majority stake in Bedfont Scientific, strengthening growth prospects for non-invasive breath analyzers.

Short Conclusion

The breath analyzer market is positioned for sustained growth driven by the convergence of enforcement requirements, non-invasive diagnostics, and technological innovation. The transition from alcohol-testing dominance toward integrated public safety and healthcare applications represents a fundamental shift in breath analysis. While challenges related to clinical validation, calibration burdens, and regulatory fragmentation persist, strategic investments in sensor performance, digital connectivity, and clinical evidence are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with breath analyzers evolving into a critical component of both public safety and precision medicine, supporting impaired-driving enforcement, disease screening, and improved patient outcomes across global healthcare systems.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREATH ANALYZER MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Fuel Cell Sensor
5.3. Semiconductor Sensor
5.4. Infrared (IR) Absorption
5.5. Other Technologies

6. BREATH ANALYZER MARKET BY APPLICATION

6.1. Introduction
6.2. Alcohol Detection
6.3. Drug Abuse Detection
6.4. Asthma Detection
6.5. Tuberculosis Detection
6.6. Others

7. BREATH ANALYZER MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Law Enforcement Agencies
7.5. Homecare Settings
7.6. Others

8. BREATH ANALYZER MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Technology
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Technology
- 8.3.2. By Application
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Technology
- 8.4.2. By Application
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Technology
- 8.5.2. By Application
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Technology
- 8.6.2. By Application
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. Japan
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Others